3 Stocks Moving The Health Services Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 28 points (0.2%) at 16,953 as of Monday, June 9, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,914 issues advancing vs. 1,041 declining with 157 unchanged.

The Health Services industry currently sits up 0.6% versus the S&P 500, which is up 0.2%. Top gainers within the industry include Insulet ( PODD), up 4.5%, Opko Health ( OPK), up 2.2% and Bruker ( BRKR), up 1.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Agilent Technologies ( A) is one of the companies pushing the Health Services industry higher today. As of noon trading, Agilent Technologies is up $0.51 (0.9%) to $59.52 on light volume. Thus far, 490,312 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $58.70-$59.58 after having opened the day at $59.00 as compared to the previous trading day's close of $59.01.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $19.5 billion and is part of the health care sector. Shares are up 3.2% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

What a Difference a Day Makes for New SEC Rule

Jim Cramer: Agilent Technology Has Been One of My Favorites

Jim Cramer -- Agilent Is 'Continuing to Defy Gravity'

Biotech Movers: Disappointment for Bristol-Myers Kidney Combo Boosts Exelixis